Showing results (141-150 of 349) with videos related to
Sort By:
Pageof 35
Laboratory Investigation; a Journal of Technical Methods and Pathology|September 25, 1999
Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissuesG P Nielsen, A O Stemmer-Rachamimov, J Shaw, et al.Journal of Neuropathology and Experimental Neurology|December 6, 2006
Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survivalMasahiro Mizoguchi, Rebecca A Betensky, Tracy T Batchelor, et al.Journal Des Maladies Vasculaires|October 22, 2011
[Mycotic aortic aneurysm infected by Clostridium septicum: a case report and review of the literature]S Krypciak, E Baudry, N Louis, et al.Human Pathology|September 28, 2013
Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomasCaitlin Ann Routhier, Mark C Mochel, Kerry Lynch, et al.Hepatology (Baltimore, Md.)|January 1, 1994
Disulfide bond formation between dimeric immunoglobulin A and the polymeric immunoglobulin receptor during hepatic transcytosisK R Chintalacharuvu, A S Tavill, L N Louis, et al.Acta Neuropathologica|October 18, 2001
Clear cell pleomorphic xanthoastrocytoma: case reportJ Primavera, D C Nikas, A A Zamani, et al.International Journal of Radiation Oncology, Biology, Physics|June 28, 2005
Genetic analyses for predictors of radiation response in glioblastomaHelen A Shih, Rebecca A Betensky, Molly V Dorfman, et al.American Journal of Clinical Pathology|May 20, 2014
VE1 antibody immunoreactivity in normal anterior pituitary and adrenal cortex without detectable BRAF V600E mutationsDaniel A Mordes, Kerry Lynch, Sharon Campbell, et al.The American Journal of Pathology|December 14, 1999
Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivationG P Nielsen, A O Stemmer-Rachamimov, Y Ino, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2009
MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistanceStephen Yip, Jiangyong Miao, Daniel P Cahill, et al.Pageof 35